Cancer Care Institute

What Cancer Care Institute does

Cancer Care Institute is an independent outpatient radiation oncology practice operating under the legal entity The Practice of Morteza Dowlatshahi, MD, Inc., with headquarters in San Jose, California and a satellite facility in Morgan Hill serving the South Bay and Morgan Hill/Gilroy catchment areas of Northern California. Founded in 2002, the practice delivers a comprehensive radiation oncology service portfolio including external beam modalities (IMRT, VMAT, SBRT, IGRT, 3D CT Planning), internal radiation modalities (HDR Brachytherapy, Accelerated Partial Breast Irradiation, AccuBoost image-guided breast brachytherapy), and a proprietary Lung Symmetry tumor-tracking method, treating seven primary cancer types: bladder, breast, cervical, head and neck, lung, prostate, and uterine cancers.

The underlying technology platform centers on a General Electric Wide Bore CT Simulation Scanner feeding an advanced treatment planning system capable of over 1 trillion calculations, with delivery via linear accelerators and image-guided systems. The clinical team comprises three board-certified radiation oncologists, two board-certified medical physicists, a certified medical dosimetrist, radiation therapists, oncology nurses, and administrative staff. The practice earned American College of Radiation Oncology (ACRO) accreditation in 2020 and conducts research in collaboration with Regional Medical Center of San Jose.

The business model is fee-for-service radiation oncology reimbursed through insurance contracts (the practice accepts nearly all insurances and will pursue single-case contracts for non-contracted payers). Go-to-market is sales-led via physician referral, with a network of over 800 specialist and primary care physicians serving as the primary demand channel; the practice also accepts self-referred patients via phone and website. There is no disclosed funding, external investment, or M&A activity, and revenue and headcount trends are not publicly reported.

Name

Cancer Care Institute

Legal name

The Practice of Morteza Dowlatshahi, MD, Inc.

Website

https://cancercareinstitute.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Cancer Care Institute is an independent outpatient radiation oncology practice in San Jose, California, founded in 2002, treating breast, prostate, lung, and other cancers using IMRT, VMAT, SBRT, brachytherapy, and image-guided techniques, serving patients referred by over 800 physicians across Northern California's South Bay.

Ownership category

akta.pro rank

Product category

Radiation Oncology

NAICS

Outpatient Care Centers (6214), Offices of Physicians (62111)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH), Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology) (EUAKAIAD)

Keywords

• Radiation oncology services
• Cancer treatment center
• External beam radiation therapy
• Brachytherapy services
• Outpatient oncology

Headquarters

HQ city

San Jose

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Radiation Oncology Services: Provides comprehensive radiation therapy treatments for various cancer types, including external beam radiation, brachytherapy, and stereotactic radiosurgery. Services are billed through insurance, Medicare, and other payer arrangements.
2. Insurance Reimbursement: The institute accepts nearly all insurance plans and will attempt to secure contracts with insurance providers they are not contracted with. Revenue is generated through reimbursement for medical services provided.
3. Professional Services: Consultation, treatment planning, and follow-up services for cancer patients, billed as professional services through standard medical billing channels.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Outpatient radiation oncology center providing advanced external beam radiation therapy (IMRT, VMAT, SBRT, IGRT) and HDR Brachytherapy for bladder, breast, cervical, head and neck, lung, prostate, and uterine cancers. The practice operates from San Jose and Morgan Hill, California, under a multidisciplinary clinical team with ACRO accreditation.

Product overview

Cancer Care Institute offers a comprehensive radiation oncology platform with multiple treatment technologies. The core offerings include external radiation therapies (IMRT, VMAT, SBRT, IGRT, 3D CT Planning) and internal brachytherapy treatments (APBI, AccuBoost, HDR Brachytherapy), along with specialized Lung Symmetry for tumor tracking. The institute provides treatment for seven cancer types: bladder, breast, cervical, head and neck, lung, prostate, and uterine cancers. The treatment planning system utilizes wide bore GE CT scanning with advanced dose calculation algorithms, and treatments are delivered using linear accelerator technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Intensity-Modulated Radiation Therapy (IMRT) External beam radiation therapy that shapes radiation dose to conform to tumor geometry, delivered on an outpatient basis to cancer patients across multiple tumor types.
• Volumetric Modulated Arc Therapy (VMAT) External beam radiation technique that delivers a sculpted dose while the treatment machine rotates continuously around the patient, used for cancer patients.
• Stereotactic Body Radiation Therapy (SBRT) High-precision, high-dose radiation delivered in a small number of sessions to well-defined tumors, used for cancer patients.
• Image-Guided Radiation Therapy (IGRT) External beam radiation therapy that uses imaging taken at the time of treatment to improve targeting accuracy and reduce dose to normal tissue, used for cancer patients.
• HDR Brachytherapy Internal radiation therapy in which a high-dose-rate radioactive source is temporarily placed inside or near the tumor to deliver a conformal, high radiation dose, used for cancer patients.

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

One partnership is on record.

• Regional Medical Center of San JosecoreStrategic or Co-development PartnerCancer Care Institute collaborates with Regional Medical Center of San Jose. Dr. Dowlatshahi serves as Chairman of Cancer Services at Regional Medical Center and was Chief of Staff 2016-2018. Multiple research studies are conducted in partnership with the medical center's departments including Medical Oncology, ENT, and radiation oncology staff.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• US Oncology Network (McKesson / Ontada): One of the largest networks of community-based oncology practices in the United States, including radiation oncology services. Operates at vastly greater scale and serves as both a direct competitor and a likely acquirer of independent radiation oncology groups like Cancer Care Institute.
• GenesisCare: Global cancer care provider offering radiation oncology across hundreds of centers in the U.S. and Australia. Competes with Cancer Care Institute for radiation oncology referrals and is an active consolidator of independent practices in the outpatient setting.
• Stanford Health Care – Stanford Cancer Center: NCI-designated academic cancer center providing comprehensive radiation oncology services in the South Bay. Competes with Cancer Care Institute for complex cases and high-acuity referrals in the same San Jose-adjacent geography.
• Sarah Cannon (HCA Healthcare): HCA Healthcare's oncology network providing community-based radiation and medical oncology across the U.S. Comparable service line to Cancer Care Institute, with greater scale and capital base, and active in Bay Area hospital systems.

Direct peers

• 21st Century Oncology (Integrated Oncology Network): Operates a large network of freestanding radiation oncology centers in the U.S., directly comparable in service mix (IMRT, IMRT, SBRT, brachytherapy) to Cancer Care Institute; competes for community oncologist referrals and physician network affiliations.
• Regional Cancer Care Associates: Multi-site community oncology and radiation oncology practice group on the East Coast offering IMRT, IGRT, SBRT, and HDR brachytherapy. Highly comparable operating model (independent physician practice, hospital partnerships, referral-driven) to Cancer Care Institute.
• Compass Oncology: Independent, multi-site community oncology practice in the Pacific Northwest offering medical oncology, radiation oncology, and integrated cancer care. Closely comparable in scale, multi-site structure, and community-based referral-driven business model.
• Epic Care: Independent, multi-specialty medical group based in the East Bay/San Francisco Bay Area offering hematology, oncology, and related services. Directly comparable as a community-based, independent Bay Area oncology practice competing for overlapping patient and referral pools.

Others

• Varian (Siemens Healthineers): Leading manufacturer of linear accelerators, treatment planning systems, and radiation oncology software used by Cancer Care Institute. Not a direct competitor but a strategic vendor and ecosystem participant whose technology roadmap shapes competitive dynamics for the practice.
• Elekta: Global provider of radiation therapy and radiosurgery hardware and software. Like Varian, not a direct competitor but the principal alternative equipment vendor whose technology choices influence Cancer Care Institute's capital planning and competitive positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CancerCareInstitute
• LinkedInlinkedin.com/company/about

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Care Institute